• DOPO 25 ANNI ABBIAMO TROVATO GRANDI SODDISFAZIONI

    25 years of key innovations and rewards

  • PARTIAMO DALL'ASCOLTO PER ARRIVARE AI RISULTATI

    Listening is the starting point of our results

  • OGNI RISORSA E' UNA GRANDE OPPORTUNITA'

    Each employee is a big opportunity

Sidam - Distretto Biomedicale

25 YEARS OF SIDAM

Founded in the heart of Mirandola’s biomedical district, in just twenty-five years SIDAM managed to become a leader in the European biomedical sector thanks to major investments in research and development.

By following up on and meeting the needs of hi-tech medical centres and of specialists in the biomedical sector, over the years the company has grown and expanded at the international level.

Today, we do business in 19 Countries throughout the world, and the export sector continues to be the engine that drives our growth.

We have overcome several challenges and went through some difficult times, such as the destruction caused by the earthquake that hit Mirandola in 2012, but we are now working double shifts in order to complete the many projects in which we are involved.

PRODUCTS

  • Sidam - Nutrivent

    NUTRIVENT

  • Sidam - Optivent

    OPTIVENT

 

PININFARINA AWARD

The company has won the 'Imprese X Innovazione - Andrea Pininfarina Award’, assigned by Confindustria for having successfully invested in research and innovation.

This is the first innovation award in Europe to have adopted the parameters of the European Foundation for Quality Management (EFQM) and participates, for the Industry and Services category, to the Prize of Prizes, an award set up by the President of the Council of Ministers on a mandate by the President of the Italian Republic.

SIDAM BUYS MAJORITY STAKE IN BTC MEDICAL EUROPE

We acquired a 75% stake in BTC Medical Europe, leader company in the postoperative blood recovery and oncology sectors and based in Valeggio sul Mincio (VR) and in Nonantola (MO).

The goal is to establish an entirely Italian biomedical centre and to enhance our portfolio of products and markets.

 

SIDAM TAKES PART TO THE EUROPEAN RADIOLOGY CONGRESS

The European Radiology Congress - ECR 2017 (Wien, 1/5 march 2017) it’s the most important event in the continent, the second worldwide and Sidam can’t miss it. It’s a trend setting, dynamic environment where leading companies of the sector are taking the opportunity to discuss and present the latest technology progresses of the industry, with a particular focus on the newest generation of radiology professionals.

SIDAM "SPEAKS" AMERICAN

Another important milestone reached by Sidam: Mirandola's production site obtained from FDA (Food and Drug Administration) the Registration Number, which qualifies the company as a production workshop authorized to produce for the United States of America. This certification ensures, also for the North American market, the safety and efficacy of biomedical devices produced by the company, already recognized by the various awarding bodies responsible for Europe, South America and Asia. This recognition will allow Sidam to significantly expand its international business opportunities in the biomedical sector.